VERV•benzinga•
Verve Therapeutics Reports Results for Heart-2 Trial, Achieving 69% LDL-C Reduction with VERVE-102
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 14, 2025 by benzinga